Depression + inflammation: A bad combo for lung cancer patients
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Jul-2025 19:10 ET (3-Jul-2025 23:10 GMT/UTC)
For the first time, researchers have found that lung cancer patients who have a combination of high levels of depression and inflammation at diagnosis are later found with continuing depressive symptoms in the next several months, even as they receive new, promising therapies. The study found that having both maladies at diagnosis predicted higher, continuing levels of depression during the next eight months. Those who had only high levels of depression or only high levels of inflammation, or neither of them, showed no changes in depression over time.
In this April 2025 issue of Translational Lung Cancer Research, a pioneering study, led by Professor Shuben Li from the First Affiliated Hospital of Guangzhou Medical University, revisits a classic but unresolved question in airway surgery: Should tracheobronchial anastomoses be routinely wrapped following resection and reconstruction?
The article, titled "Tracheobronchial resection and reconstruction: to wrap or not to wrap the anastomosis?",presents a single-center experience to explore the relationship between wrapping the anastomosis after airway reconstruction and short-term surgical outcomes, and to investigate whether wrapping the anastomosis can reduce the incidence of postoperative adverse events.
Recent findings shed new light on the critical role of TET1, a pivotal player in epigenetic regulation, in the development and progression of various clinical diseases. As an enzyme responsible for DNA demethylation, TET1 influences gene expression by modifying methylcytosine levels, which are crucial for maintaining genomic stability and proper cellular function.
This new review article highlights the critical role of ribosome biogenesis in liver health and disease progression. As the center of protein synthesis, ribosomes influence liver regeneration, hepatitis C virus (HCV) infection, nonalcoholic fatty liver disease (NAFLD), liver fibrosis, cirrhosis, and hepatocellular carcinoma. The article explores how disruptions in this process contribute to disease and how targeted therapies could offer new treatment avenues.
A new review brings to light the pivotal role of ribonucleases (RNases) in shaping the molecular foundation of Mendelian disorders. These essential enzymes, known for maintaining RNA metabolism, are revealed as central players in a diverse spectrum of human diseases. When disrupted by genetic mutations, RNases lose their ability to regulate RNA dynamics, giving rise to neurological, growth-related, hematopoietic, and mitochondrial dysfunctions.
A new review from Genes and Diseases sheds light on the pivotal role of LINE-1 elements in preimplantation development and totipotency, revealing their essential contributions to early mammalian embryogenesis. Once considered mere genomic relics, these transposable elements are now recognized as crucial regulators of cellular fate and developmental progression.